Skip to main content
. 2020 Oct 15;30(3):030901. doi: 10.11613/BM.2020.030901

Table 1. Comparison of rapid BYOSINEX COVID-19 BSS with the MAGLUMI 2019-nCoV for SARS-CoV-2 IgM and IgG detection.

MAGLUMI 2019-nCov
SARS-CoV-2 IgM Positive Negative Total
Positive 24 (34%) 5 (7%) 29 (41%)
BIOSYNEX COVID-19 BSS Negative 5 (7%) 36 (51%) 41 (59%)
Total 29 (41%) 41 (59%) 70 (100%)
MAGLUMI 2019-nCov
SARS-CoV-2 IgG Positive Negative Total
Positive 36 (51%) 2 (3%) 38 (54%)
BIOSYNEX COVID-19 BSS Negative 8 (11%) 24 (34%) 32 (46%)
Total 44 (63%) 26 (37%) 70 (100%)